Page last updated: 2024-11-05

pentadecanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pentadecanoic acid, also known as pentadecylic acid, is a saturated fatty acid with the formula CH3(CH2)13COOH. It is a white, waxy solid at room temperature. Pentadecanoic acid is found naturally in various plants and animal fats, including milk, butter, and beeswax. It has been shown to possess anti-inflammatory and antimicrobial properties. Researchers are interested in studying pentadecanoic acid due to its potential therapeutic applications, particularly in the treatment of inflammatory diseases. Studies have explored its effects on immune cells and its ability to modulate inflammatory pathways. Synthetically, pentadecanoic acid can be produced through various methods, including the hydrogenation of palmitoleic acid. The interest in pentadecanoic acid is driven by its potential as a valuable component in pharmaceuticals, cosmetics, and food additives.'

pentadecanoic acid: in serum as a marker for intake of milk fat [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pentadecanoic acid : A straight-chain saturated fatty acid containing fifteen-carbon atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID13849
CHEMBL ID460025
CHEBI ID42504
SCHEMBL ID6311
MeSH IDM0300580

Synonyms (67)

Synonym
unii-ccw02d961f
ccw02d961f ,
4-02-00-01147 (beilstein handbook reference)
nsc-28486
pentadecylic acid
nsc28486
1002-84-2
n-pentadecanoic acid
wln: qv14
pentadecanoic acid
ai3-36441
pentadecyclic acid
einecs 213-693-1
nsc 28486
brn 1773831
n-pentadecylic acid
pentadecanoic acid, ~99% (capillary gc)
CHEBI:42504 ,
c15:0
LMFA01010015
F15 ,
9B1C70C0-EF6E-4FCF-A3D3-DACCDCCF791C
bdbm50242348
BMSE000558
CHEMBL460025 ,
P0035
NCGC00248954-01
pentadecansäure
tox21_201197
dtxcid601652
NCGC00258749-01
dtxsid2021652 ,
cas-1002-84-2
AKOS015903762
S6234
pentadecanoic acid [fhfi]
fema no. 4334
SCHEMBL6311
tetradecylcarboxylic acid
tetradecyl carboxylic acid
64118-45-2
mfcd00002745
STL453783
J-000083
pentadecanoic acid, analytical standard
pentadecanoic acid, 99%
pentadecanoic acid, >=99%
CS-W004283
fa 15:0
n-pentadecylate
pentadecyclate
n-pentadecanoate
HY-W004283
SY009985
n-pentadecanoicacid
Q418951
FT-0738251
AMY5935
pentadecanoic'acid
H10804
A897509
pentadecanoic acid; n-caprylic acid sodium salt
2,2-dideuteropentadecanoic acid
AS-57005
fa 15:0a
EN300-176407
BP-27916

Research Excerpts

Overview

Pentadecanoic acid (C15:0) is an essential odd-chain saturated fatty acid with broad activities relevant to protecting cardiometabolic, immune, and liver health.

ExcerptReferenceRelevance
"Pentadecanoic acid (C15:0) is an essential odd-chain saturated fatty acid with broad activities relevant to protecting cardiometabolic, immune, and liver health. "( Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds.
Schork, NJ; Venn-Watson, S, 2023
)
3.8

Pharmacokinetics

ExcerptReferenceRelevance
" The ratio of HA to PA Cmax and AUC was also calculated and compared."( Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis.
Barrett, JS; Mascarenhas, MR; Mondick, JT; Schall, JI; Stallings, VA; Wilson, M, 2013
)
0.62

Dosage Studied

ExcerptRelevanceReference
" Pentadecanoic acid induced significant oviposition stimulation, especially when dosed at 10 ppm."( Behavioural and antennal responses of Aedes aegypti (l.) (Diptera: Culicidae) gravid females to chemical cues from conspecific larvae.
Boullis, A; Delannay, C; Héry, L; Mulatier, M; Vega-Rúa, A; Verheggen, F, 2021
)
1.53
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
food componentA physiological role played by any substance that is distributed in foodstuffs. It includes materials derived from plants or animals, such as vitamins or minerals, as well as environmental contaminants.
Daphnia magna metaboliteA Daphnia metabolite produced by the species Daphnia magna.
human blood serum metaboliteAny metabolite (endogenous or exogenous) found in human blood serum samples.
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
long-chain fatty acidA fatty acid with a chain length ranging from C13 to C22.
straight-chain saturated fatty acidAny saturated fatty acid lacking a side-chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency89.65000.007215.758889.3584AID1224835
AR proteinHomo sapiens (human)Potency17.97070.000221.22318,912.5098AID743042; AID743054
farnesoid X nuclear receptorHomo sapiens (human)Potency55.12250.375827.485161.6524AID743217
estrogen nuclear receptor alphaHomo sapiens (human)Potency55.20760.000229.305416,493.5996AID743075; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency43.06010.001024.504861.6448AID743212; AID743227
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prostaglandin G/H synthase 1 Bos taurus (cattle)IC50 (µMol)500.00000.00051.41288.2000AID360928
Prostaglandin G/H synthase 2Ovis aries (sheep)IC50 (µMol)500.00000.00101.453910.0000AID360927
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
response to oxidative stressProstaglandin G/H synthase 1 Bos taurus (cattle)
cellular oxidant detoxificationProstaglandin G/H synthase 1 Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
peroxidase activityProstaglandin G/H synthase 1 Bos taurus (cattle)
heme bindingProstaglandin G/H synthase 1 Bos taurus (cattle)
metal ion bindingProstaglandin G/H synthase 1 Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneProstaglandin G/H synthase 1 Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID360928Inhibition of bovine COX1-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid2001Journal of natural products, Jun, Volume: 64, Issue:6
Cox-2 inhibitory effects of naturally occurring and modified fatty acids.
AID376615Inhibition of aromatase in human placental microsomes at 20 ug/ml by radiometric method relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay.
AID360927Inhibition of sheep COX2-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid2001Journal of natural products, Jun, Volume: 64, Issue:6
Cox-2 inhibitory effects of naturally occurring and modified fatty acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (94)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (4.26)18.7374
1990's1 (1.06)18.2507
2000's29 (30.85)29.6817
2010's44 (46.81)24.3611
2020's16 (17.02)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.56 (24.57)
Research Supply Index4.67 (2.92)
Research Growth Index5.49 (4.65)
Search Engine Demand Index112.78 (26.88)
Search Engine Supply Index3.16 (0.95)

This Compound (47.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (8.16%)5.53%
Reviews4 (4.08%)6.00%
Case Studies1 (1.02%)4.05%
Observational2 (2.04%)0.25%
Other83 (84.69%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]